QUOTED. 29 August 2019. Tim Herbert.
Executive Summary
Medicare administrative contractors for 19 US states have proposed supplying local Medicare coverage for hypoglossal nerve stimulation (HNS) provided by Inspire Medical Systems’ Inspire therapy to treat obstructive sleep apnea. See what company president and CEO Tim Herbert said about it here.
“This is a very positive advance for the Medicare-aged population that can streamline their access to Inspire therapy.” – Tim Herbert, president and CEO, Inspire Medical Systems
- Find out more: CMS Contractors Propose LCD Payments For Inspire Medical’s Sleep Apnea Nerve Stimulation Device
Click here for a free trial of Medtech Insight